Ogenix to Participate in Third Congress of the World Union of Wound Healing Societies in Toronto

Ogenix, a medical technology company that develops and markets a breakthrough device used in treatment of chronic and acute wounds, announced today the company's participation in the Third Congress of the World Union of Wound Healing Societies in Toronto, Ontario on June 4th-8th, 2008. Ogenix’s Canadian Distributor, Converg Medical Corporation will also be present at the conference.

Sample devices will be presented and demonstrations will be conducted at Booth # 2122 throughout the conference.

The EpiFLO® device has demonstrated the ability to effectively treat chronic wounds by delivering a sustained stream of oxygen directly to the wound bed, resulting in closure of many wounds that have previously failed standard wound care and other adjunct therapies.

According to Dr. Sarang Sarangapani, President of Ogenix, "Oxygen therapy within wound care has evolved rapidly in recent years and will soon be considered as part of the standard treatments of many types of wounds. Our device, The EpiFLO®, has been responsible for the closure of many wounds that had resulted in scheduled amputations. Not only has it averted many such amputations, it has completely closed these wounds in an average of 8 weeks time."

The Ogenix exhibit will enable health care professionals to view the device and discuss its role in wound care treatment with company executives.

About Third Congress of the World Union of Wound Healing Societies

The primary goal of the World Union of Wound Healing Societies 2008 Congress, sponsored and hosted by the University of Toronto, will be to present the wound care evidence base and transfer the knowledge, skills, and attitudes for improved patient outcomes. This will be accomplished through a five-day meeting that includes a pre-conference day, three plenary sessions, and 10 concurrent streams with more than 100 educational sessions.

About Ogenix

Ogenix is a medical device developer that manufactures and markets the EpiFLO®, a palm sized medical device used in sustained oxygen delivery for chronic wound treatment. For additional information, please refer to their website at www.ogenix.com.